Clinical Trial Update: Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

View source ↗

Summary

Clinical trial update for Eliquis assessing treatment and prevention of recurrent venous thromboembolism; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Venous Thromboembolism | Status: COMPLETED